---
title: "Rapid Micro Biosystems 1Q 2026: Revenue $8M, EPS ($0.31) — 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286558834.md"
description: "Rapid Micro Biosystems reported Q1 2026 revenue of $8M, up 11.1% from $7.21M a year ago, but recorded a net loss of $14.28M and diluted EPS of ($0.31). Product revenue increased by 36%, with recurring revenue at 63.3% of total. The company entered a distribution agreement with MilliporeSigma and has placed 196 systems, focusing on sales and marketing investments."
datetime: "2026-05-15T11:41:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286558834.md)
  - [en](https://longbridge.com/en/news/286558834.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286558834.md)
---

# Rapid Micro Biosystems 1Q 2026: Revenue $8M, EPS ($0.31) — 10-Q Summary

Rapid Micro Biosystems reported first-quarter 2026 results, with revenue rising to $8M from $7.21M a year earlier while the company recorded a net loss of ($14.28M) and diluted loss per share of ($0.31).

**Financial Highlights**

Metric

Current quarter

Prior year quarter

YoY change

Revenue¹

$8M

$7.21M

11.1%

Net income²

($14.28M)

($11.26M)

(26.7%)

Diluted EPS³

($0.31)

($0.26)

(19.2%)

_¹ Reported as “Total revenue”. ² Reported as “Net loss”. ³ Reported as “loss per share — basic and diluted”._

**Business Highlights**

-   Product revenue rose 36% year-over-year, driven by increased system placements and higher consumable shipments.
-   Recurring revenue increased to 63.3% of total, led by consumables and service contracts from validated systems.
-   Entered a global co-exclusive distribution agreement with MilliporeSigma to expand reach and pursue supply-cost synergies.
-   Cumulative system placements reached 196, with growing multi-site adoption and ramping consumable throughput.
-   The company increased investments in sales, marketing and service hiring to support demos, LIMS sales and customer validation.

Original SEC Filing: RAPID MICRO BIOSYSTEMS, INC. \[ RPID \] - 10-Q - May. 15, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [RPID.US](https://longbridge.com/en/quote/RPID.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)

## Related News & Research

- [Rapid Micro Biosystems Raises $8.9M Net in Underwritten Offering, Adds $140K D&O Purchase](https://longbridge.com/en/news/286969296.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Lifeward Delays Quarterly Report Amid Deal Accounting](https://longbridge.com/en/news/286586728.md)
- [Coherent Corp. Rocked by Major Insider Stock Move From Company Director](https://longbridge.com/en/news/286343834.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)